News & events

Treatment cuts migraine days by half

A new King’s College London study, published in the New England Journal of Medicine (NEJM), shows treatment with a drug called erenumab cut the number of days with migraine symptoms for 50 per cent of patients.   

By NIHR Maudsley BRC at 30 Nov 2017

Study examines opiate-dependent patient deaths

A new study  has examined the high number of opiate-dependent patient deaths immediately after being transferred as well as after ending opioid substitution therapy.

By NIHR Maudsley BRC at 28 Nov 2017

Complications at birth associated with lasting chemical changes in the brain

New King’s College London research, published today (28 November) in eLife, shows that adults born prematurely - who also suffered small brain injuries around the time of birth - have lower levels of dopamine in the brain.

By NIHR Maudsley BRC at 28 Nov 2017

Concentrated naloxone nasal spray as good as injection

A new study published by the scientific journal Addiction has found that a concentrated 2mg intranasal naloxone spray delivers naloxone as effectively, over the critical first 15 minutes, as the standard 0.4mg intramuscular (IM) naloxone injection. The research was co-authored by Professor Sir John Strang and Dr Rebecca McDonald, National Addiction Centre, Institute of Psychiatry, Psychology & Neuroscience (IoPPN), King’s College London.

By NIHR Maudsley BRC at 20 Nov 2017

First network analysis of patient flow in two UK hospitals published

Researchers at the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London and King’s College Hospital NHS Foundation Trust, have used network science to analyse patient flow through a hospital for the first time in a UK health system.

By NIHR Maudsley BRC at 8 Nov 2017